OpenAI CEO advocates AI licensing for Congress

Read time: 4 minutes

Welcome to your daily dose of AI insights! Get ready to dive into today's top five handpicked AI news stories, designed to keep you in the loop.

1. Open AI CEO Urges Congress to Consider Licensing Requirements for Powerful Artificial Intelligence

OpenAI's CEO, Sam Altman, is set to testify before Congress advocating for the consideration of licensing or registration requirements for companies developing advanced artificial intelligence (AI) technologies.

Altman believes that such regulations would ensure adherence to safety standards, including pre-release testing and transparent reporting of results. With concerns about societal harms and the misuse of AI, this move aims to establish oversight and accountability. While some experts caution against potential drawbacks such as hindering smaller players, Altman emphasizes the need for a flexible governance regime and global cooperation.

The hearing signals an important step towards comprehensive AI oversight in the United States.

Read the full story here

2. European Parliament Committee Approves Landmark AI Regulation, Sets Risk-Based Approach

Lawmakers in the European Parliament have achieved a significant milestone by approving the European AI Act, the first-of-its-kind regulation for AI systems in the West.

The legislation takes a risk-based approach, categorizing AI applications into different levels of risk. Unacceptable risk applications are banned, and providers of "foundation models" like ChatGPT face additional requirements such as safety checks, data governance, and copyright compliance. The aim is to ensure fundamental rights, health, safety, and environmental protection.

The rules still need further steps to become law but are seen as a global standard for AI regulation. Tech industry reactions and concerns have also emerged.

Read the full story here

3. Google Cloud Launches AI-Powered Tools for Accelerating Drug Discovery in Biotech and Pharma

Google Cloud has unveiled two new AI-powered tools aimed at aiding biotech and pharmaceutical companies in speeding up drug discovery and advancing precision medicine.

The Target and Lead Identification Suite assists in predicting and understanding protein structure, a crucial aspect of drug development. Meanwhile, the Multiomics Suite helps researchers ingest, store, analyze, and share large amounts of genomic data. The suites address challenges faced by the biopharma industry, offering significant time and cost savings.

The move solidifies Google's position in the competitive AI landscape and provides solutions to the extensive research process involved in bringing new medicines to market.

Read the full story here

4. Microsoft Researchers Spark Debate with Claims of Advancements in Artificial General Intelligence

Microsoft researchers have published a research paper claiming that their AI system, OpenAI's GPT-4, demonstrates characteristics of artificial general intelligence (A.G.I.), capable of human-like reasoning and generating creative ideas.

The paper, titled "Sparks of Artificial General Intelligence," sparked a contentious debate in the tech industry. Critics argue that such claims lack scientific rigor and may be overstated. GPT-4's ability to solve complex problems and generate text has impressed researchers, but there are concerns about consistency and the system's understanding of the physical world.

The discussion highlights the ongoing challenges and controversies surrounding the pursuit of A.G.I.

Read the full story here

5. Generative AI Reshapes Marketing and Sales, Redefining Customer Experience and Productivity

Artificial intelligence (AI) and machine learning (ML) have transformed the marketing and sales landscape.

Now, with the emergence of generative AI (gen AI), businesses are experiencing a new wave of innovation. Gen AI, supported by open-source platforms and increased investment, is automating sales functions and revolutionizing customer experience. From hyper-personalization to growth acceleration and productivity enhancement, gen AI is driving marketing and sales effectiveness. However, leaders must navigate the risks and challenges associated with AI adoption, including data privacy and security.

Those who strategically invest in gen AI can unlock revenue uplift and gain a competitive edge in the market.

Read the full story here

That's a wrap for today's AI insights. Remember, in the world of AI, Pivot is your compass. Stay curious, stay informed.

Thanks for reading.

P.S.: Continue your AI journey with Pivot across all platforms. From social media to Discord, Slack, and Telegram, we're there. Follow us where it's most convenient for you and stay up-to-date with the latest AI insights.